Lv11
50 积分 2024-04-20 加入
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
3个月前
已完结
Data from AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
6个月前
已完结
Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study
6个月前
已完结
CD300ld on neutrophils is required for tumour-driven immune suppression
7个月前
已完结
Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial
8个月前
已完结
IL-18 as critical co-stimulatory molecules in modulating the immune response of ITAM bearing lymphocytes
9个月前
已完结
Co-expression of IL-4/IL-15-based inverted cytokine receptor in CAR-T cells overcomes IL-4 signaling in immunosuppressive pancreatic tumor microenvironment
9个月前
已完结
From suppressor to enhancer: IL-10’s alternative role in CAR-T cell therapies against solid tumors
9个月前
已完结
Abstract 1803: ACOD1 is a key regulator of immunosuppressive MDSCs, prostate cancer progression, and resistance to immunotherapy
9个月前
已关闭
[Current Trend of CAR-T Cell Therapy for Metastatic Castration-Resistant Prostate Cancer]
10个月前
已完结
皖公网安备34019202002308
